O'Brien Greene & Co. Inc Abbott Laboratories Transaction History

O'Brien Greene & Co. Inc

$291 Million
Q4 2024

A detailed history of O'Brien Greene & Co. Inc transactions in Abbott Laboratories stock. As of the latest transaction made, O'Brien Greene & Co. Inc holds 11,159 shares of ABT stock, worth $1.46 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares

11,159

Previous 11,137 0.2%

Holding current value

$1.46 Million

Previous $1.27 Million 0.55%

% of portfolio

0.43%

Previous 0.42%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 03, 2025	BUY	$111.93 - $119.39 $2,462 - $2,626	22 Added 0.2%	11,159 $1.26 Million
Q3 2024 Nov 15, 2024	SELL	$100.07 - $118.13 $23,216 - $27,406	-232 Reduced 2.04%	11,137 $1.27 Million
Q2 2024 Aug 12, 2024	SELL	$100.73 - $112.44 $32,233 - $35,980	-320 Reduced 2.74%	11,369 $1.18 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $11,273 - $13,800	-125 Reduced 1.06%	11,689 $1.29 Million
Q3 2023 Nov 08, 2023	BUY	$95.53 - $114.62 $19,106 - $22,924	200 Added 1.72%	11,814 $1.14 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $2.13 Million - $2.37 Million	-21,128 Reduced 64.53%	11,614 $1.27 Million
Q2 2023 Jul 20, 2023	BUY	$100.78 - $112.29 $2.16 Million - $2.4 Million	21,393 Added 188.5%	32,742 $3.57 Million
Q4 2022 Feb 02, 2023	SELL	$95.06 - $111.52 $2.2 Million - $2.58 Million	-23,109 Reduced 67.06%	11,349 $1.25 Million
Q3 2022 Nov 09, 2022	BUY	$96.76 - $112.03 $2.22 Million - $2.57 Million	22,972 Added 200.0%	34,458 $3.33 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $26,129 - $31,582	256 Added 2.28%	11,486 $1.25 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $123,386 - $151,079	-1,068 Reduced 8.68%	11,230 $1.58 Million
Q3 2021 Nov 12, 2021	BUY	$116.66 - $129.06 $8,749 - $9,679	75 Added 0.61%	12,298 $1.45 Million
Q2 2021 Aug 09, 2021	BUY	$105.79 - $124.53 $5,289 - $6,226	50 Added 0.41%	12,223 $1.42 Million
Q3 2020 Nov 09, 2020	SELL	$91.64 - $111.29 $9,164 - $11,129	-100 Reduced 0.81%	12,173 $1.33 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $11,433 - $16,718	-182 Reduced 1.46%	12,273 $969,000
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $6,045 - $6,729	-77 Reduced 0.61%	12,455 $1.08 Million
Q3 2019 Nov 07, 2019	SELL	$81.84 - $88.74 $9,493 - $10,293	-116 Reduced 0.92%	12,532 $1.05 Million
Q2 2019 Aug 21, 2019	SELL	$72.88 - $85.0 $180,378 - $210,375	-2,475 Reduced 16.37%	12,648 $1.06 Million
Q1 2019 Apr 29, 2019	SELL	$66.22 - $80.06 $1.26 Million - $1.52 Million	-19,000 Reduced 55.68%	15,123 $1.21 Million
Q4 2018 Feb 27, 2019	BUY	$65.56 - $74.27 $2.24 Million - $2.53 Million	34,123 New	34,123 $2.47 Million

Others Institutions Holding ABT

# of Institutions

3,344

Shares Held

1.36B

Call Options Held

10.7M

Put Options Held

8.87M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $229B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Brien Greene & Co. Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Brien Greene & Co. Inc with notifications on news.

Account

O'Brien Greene & Co. Inc Abbott Laboratories Transaction History